DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD)/BIOLOGIC
Kineret is a prescription medication approved by the Food and Drug Administration
to treat moderate to severe rheumatoid arthritis (RA) in adults who have not improved on other disease-modifying antirheumatic drugs (DMARDs). Kineret may be referred to by its drug name, Anakinra.
Kineret is a DMARD and a biologic. Kineret is believed to work by reducing the activity of interleukin-1 (IL-1), a molecule that contributes to autoimmune attacks in RA.
How do I take it?
Kineret is administered once daily by subcutaneous injection.
Kineret comes in the form of a prefilled, single-use syringe.
The FDA-approved label for Kineret lists common side effects including headache, flu- or cold-like symptoms, injection site reactions, nausea, diarrhea, joint pain, abdominal pain, and worsening RA symptoms.
Rare but serious side effects listed for Kineret include severe infections and allergic reactions.
For more details about this treatment, visit:
Kineret – Swedish Orphan Biovitrum